SUBSCRIBE
SUBSCRIBE
News   FDA

FDA Revises Process for Responding to Drug Applications

July 28, 2008 | 
1 min read
The U.S. Food and Drug Administration today announced that it is revising the way it communicates to drug companies when a marketing application cannot be approved as submitted.
FDA Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Collage illustration depicting legal advice, decisions
Job Trends
3 Top Challenges Facing Regulatory Professionals Right Now
February 5, 2026
 · 
4 min read
 · 
Angela Gabriel
Contemporary art collage showing a hand giving a thumbs down surrounded by red arrows pointing down, concept of negative feedback and bad review
Rare diseases
Amgen Will Not Heed FDA Request To Withdraw Rare Disease Drug Tavneos
February 4, 2026
 · 
2 min read
 · 
Annalee Armstrong
FDA signage at its headquarters in Maryland
FDA
FDA’s Commissioner’s Priority Voucher Program ‘Shrouded in Secrecy,’ Democratic Rep Says
February 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
Pfizer’s Metsera Data, 2025 Earnings, the FDA and REGENXBIO, Psychedelics and IPOs
February 4, 2026
 · 
1 min read
 · 
Heather McKenzie